Literature DB >> 12682845

Meconium-stained amniotic fluid is not a risk factor for otitis media.

Masja Straetemans1, Yvonne Schönbeck, Joost A M Engel, Gerhard A Zielhuis.   

Abstract

It has recently been hypothesised that large amounts of amniotic fluid cellular content (AFCC) in the middle ear may lead to chronic inflammation and predispose young children to recurrent middle ear infections. Because children born with meconium-stained amniotic fluid (MSAF) have higher AFCC in the middle ear, we performed a retrospective cohort study to determine whether children born with MSAF had a higher risk of OM during infancy. Children born between May 1998 and April 2000 formed two groups based on the absence or presence of MSAF at birth as documented in the hospital birth records. In April 2002, home visits were made to take tympanometric measurements and administer a questionnaire on OM history and possible confounders. Logistic regression models were constructed to assess odds ratios (OR) as a measure of the effect of MSAF on OM and to adjust for potential confounders. There were no differences in the point prevalence of a type-B tympanogram at the home visit (OR 0.81; 95% confidence interval: 0.38-1.76). Also, no statistically significant association was found between the proportion of children with OM diagnosed in the 1st year of life (OR 0.86, 95% confidence interval: 0.27-2.73) and in the proportion of children that had ever been diagnosed with OM (OR 0.91, 95% confidence interval: 0.40-2.91). It can be concluded that children born with MSAF do not constitute a high-risk group for OM in early childhood. A long-term OM effect, especially in severe MSAF cases, cannot be excluded.

Entities:  

Mesh:

Year:  2003        PMID: 12682845     DOI: 10.1007/s00405-003-0601-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  12 in total

1.  Spread of amniotic fluid cellular content within the neonate middle ear.

Authors:  T Palva; C Northrop; H Ramsay
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1999-05-05       Impact factor: 1.675

2.  Effect of amniotic fluid cellular content on attic aeration pathways: histologic observations of infants aged 2 to 4 months.

Authors:  T Palva; C Northrop; H Ramsay
Journal:  Am J Otol       Date:  2000-01

3.  Foreign body neonatal otitis media in infants.

Authors:  T Palva; C Northrop; H Ramsay
Journal:  Otol Neurotol       Date:  2001-07       Impact factor: 2.311

4.  Clinical experience with impedance audiometry.

Authors:  J Jerger
Journal:  Arch Otolaryngol       Date:  1970-10

5.  [Neonatal otitis].

Authors:  C Cioce; A Canubi
Journal:  Ann Laringol Otol Rinol Faringol       Date:  1978

6.  A meta-analytic review of the risk factors for acute otitis media.

Authors:  M Uhari; K Mäntysaari; M Niemelä
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

7.  Risk factors of otitis media with effusion during infancy.

Authors:  J Engel; L Anteunis; A Volovics; J Hendriks; E Marres
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1999-05-25       Impact factor: 1.675

8.  Spread and fate of amniotic fluid cellular content in the middle ear.

Authors:  H Ramsay; T Palva; C Northrop
Journal:  Acta Otolaryngol       Date:  2001-01       Impact factor: 1.494

9.  Abnormalities of the neonatal ear: otoscopic observations, histologic observations, and a model for contamination of the middle ear by cellular contents of amniotic fluid.

Authors:  R D Eavey
Journal:  Laryngoscope       Date:  1993-01       Impact factor: 3.325

10.  Meconium aspiration and otitis media in children.

Authors:  L Jaber; R Gabriel; P Merlob
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

View more
  1 in total

1.  Risk factors for failing the hearing screen due to otitis media in Dutch infants.

Authors:  Willeke Lok; Lucien J C Anteunis; Cor Meesters; Michelene N Chenault; Mark P Haggard
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-30       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.